These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6165288)

  • 1. Tolerability of pure fibroblast interferon in man.
    Billiau A; Heine JW; Van Damme J; Heremans H; De Somer P
    Ann N Y Acad Sci; 1980; 350():374-5. PubMed ID: 6165288
    [No Abstract]   [Full Text] [Related]  

  • 2. Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.
    Billiau A; De Somers P; Edy VG; De Clercq E; Heremans H
    Antimicrob Agents Chemother; 1979 Jul; 16(1):56-63. PubMed ID: 475375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon.
    Fleischmann WR; Georgiades JA; Osborne LC; Johnson HM
    Infect Immun; 1979 Oct; 26(1):248-53. PubMed ID: 227796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and properties of native and modified interferons.
    Pickering LA; Braude IA; Lin LS; Stewart WE
    Ann N Y Acad Sci; 1980; 350():354-63. PubMed ID: 6165287
    [No Abstract]   [Full Text] [Related]  

  • 5. Purified human fibroblast interferon in vivo: skin reactions and effect on bone marrow precursor cells.
    Carter WA; Dolen JG; Leong SS; Horoszewicz JS; Vladutiu AO; Leibowitz AI; Nolan JP
    Cancer Lett; 1979 Sep; 7(5):243-9. PubMed ID: 509407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial interaction of human fibroblast and leukocyte interferons with FS-4 fibroblasts.
    Gardner LJ; Vilcek J
    J Gen Virol; 1979 Jul; 44(1):161-8. PubMed ID: 227987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of human interferons by antibody affinity chromatography.
    Berg K; Alacam R; Hamilton RD; Heron I
    Tex Rep Biol Med; 1977; 35():187-92. PubMed ID: 358447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purified human immune interferon has more potent anticellular activity than fibroblast or leukocyte interferon.
    Blalock JE; Georgiades JA; Langford MP; Johnson HM
    Cell Immunol; 1980 Feb; 49(2):390-4. PubMed ID: 6986204
    [No Abstract]   [Full Text] [Related]  

  • 9. Interferon: pharmacokinetics and toxicity.
    Scott GM
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):91-107. PubMed ID: 6183699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of interferon in viral hepatitis B.
    Desmyter J
    Tex Rep Biol Med; 1977; 35():516-22. PubMed ID: 358473
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple active sites on human interferons.
    Paucker K; Dalton BJ; Ogburn CA; Törmä E
    Proc Natl Acad Sci U S A; 1975 Nov; 72(11):4587-91. PubMed ID: 53841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune interferon activates cells more slowly than does virus-induced interferon.
    Dianzani F; Salter L; Fleischmann WR; Zucca M
    Proc Soc Exp Biol Med; 1978 Oct; 159(1):94-7. PubMed ID: 714938
    [No Abstract]   [Full Text] [Related]  

  • 13. Human fibroblast interferon in human neoplasia: clinical and laboratory study.
    Horoszewicz JS; Leong SS; Ito M; Buffett RF; Karakousis C; Holyoke E; Job L; Dölen JG; Carter WA
    Cancer Treat Rep; 1978 Nov; 62(11):1899-906. PubMed ID: 728909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of murine and human interferons. A review of the literature of the 1970s.
    Berg K
    Acta Pathol Microbiol Immunol Scand Suppl; 1982; 279():1-136. PubMed ID: 6182743
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition by interferon of delayed-type hypersensitivity in the mouse.
    De Maeyer E; De Maeyer-Guignard J; Vandeputte M
    Proc Natl Acad Sci U S A; 1975 May; 72(5):1753-7. PubMed ID: 168573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon and spontaneous cytotoxicity in man. IV. Evidence for interferon as the factor in human interferon preparations causing enhancement of spontaneous cytotoxicity.
    Einhorn S
    J Clin Lab Immunol; 1980 Jan; 3(1):35-8. PubMed ID: 6155470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human fibroblastoid interferon: immunosorbent column chromatography and N-terminal amino acid sequence.
    Okamura H; Berthold W; Hood L; Hunkapiller M; Inoue M; Smith-Johannsen H; Tan YH
    Biochemistry; 1980 Aug; 19(16):3831-5. PubMed ID: 6157401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined immediate- and delayed-type hypersensitivity to metamizole.
    Bellegrandi S; Rosso R; Mattiacci G; Zaffiro A; Di Sora F; Menzella F; Aiuti F; Paganelli R
    Allergy; 1999 Jan; 54(1):88-90. PubMed ID: 10195371
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification of human fibroblast interferon by adsorption to controlled-pore glass and zinc-chelate chromatography.
    Heine KJ; Billiau A
    Methods Enzymol; 1981; 78(Pt A):448-56. PubMed ID: 6173627
    [No Abstract]   [Full Text] [Related]  

  • 20. Production and quantitation of neutralizing antibodies for human fibroblasts interferon.
    Havell EA
    Methods Enzymol; 1981; 79(Pt B):571-5. PubMed ID: 6173712
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.